Work

A Phase I/II Trial of Panobinostat in Combination With Lenalidomide in Patients With Relapsed or Refractory Hodgkin Lymphoma

Year: 2017

Type: article

Study design: Clinical Trial

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/j.clml.2017.05.008

Authors: Joseph J. Maly, Beth A. Christian, Xiaohua Zhu, Lai Wei, Jennifer L. Sexton, Samantha M. Jaglowski, Steven M. Devine, Todd A. Fehniger, Nina D. Wagner-Johnston, Mitch A. Phelps, Nancy L. Bartlett, Kristie A. Blum

Institutions: The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Washington University in St. Louis, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Comprehensive Cancer Center, City of Hope, National Cancer Institute

Awards: G2100020844, Development of a comprehensive research program in mantle cell lymphoma in the ibrutinib era, G4932472356, Cancer Center Support Grant

OpenAlex ID: W2620029856

FWCI: 2.409

Cites: 25

Cited by: 31

Related to: 10